AUROPHARMA

Current Price (approx.): ₹1,134–₹1,147 per share, as of mid‑2025 P/E Ratio: 19×, significantly below a fair P/E estimate of 40×, suggesting potential value opportunity “Aurobindo Pharma has reversed its downtrend, forming a double bottom and breaking above its 40‑week EMA... daily RMI turned bullish; weekly RMI nearly so. A breakout above the 20‑week MA may confirm sustained upside.”